Michael Creighton

Michael Creighton, CPA, currently serves as Head of Finance at Paratus Sciences, a position held since June 2023. Prior to this role, Michael was also Head of Finance at DynamiCure Biotechnology from August 2022 to June 2023 and held the title of Vice President - Head of Finance at NanoView Biosciences until its acquisition by Unchained Labs in August 2022. Michael's extensive experience includes various roles such as Director of Finance and Controller at KEW, Inc., and Accounting Manager at Repligen Corporation and PTC. Additionally, Michael worked as a Senior Revenue Accountant at Xcellerex and as an Audit Senior at PricewaterhouseCoopers, specializing in Pharmaceuticals and Life Sciences. Michael holds a Master of Business Administration (MBA) and a Bachelor of Business Administration (BBA) in Accounting from St. Bonaventure University.